Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 5, 2025
Discovery & Translation
Science Spotlight: A FOXP3 regulator to enhance induced Tregs
BioCentury’s roundup of translational innovations also includes insights into high-fat diet disruption of feeding motivation; ER-targeted antigens; and more
BioCentury | Mar 27, 2025
Management Tracks
Thomas Butler steps down as Biomea CEO
Plus: Shane Olwill named chief development officer of Asgard, and updates from Tevogen and Verrica
BioCentury | Mar 19, 2025
Discovery & Translation
Science Spotlight: TGFβ drives long COVID inflammation via EBV
BioCentury’s roundup of translational innovations also includes boosting T cell antitumor activity via fructose, and a new Parkinson’s risk gene
BioCentury | Feb 27, 2025
Discovery & Translation
Science Spotlight: Clues from the clinic for neoantigen prioritization
BioCentury’s roundup of translational innovations also includes causal biology for a heart condition, and the biological foundational model Evo 2
BioCentury | Feb 26, 2025
Distillery Therapeutics
Inhibition of cancer cell NDUFS4 for antitumor immunity
BioCentury | Feb 22, 2025
Discovery & Translation
Science Spotlight: Bacterial payload delivery from nose to brain
BioCentury’s roundup of translational innovations also includes targeting MSH3 to slow repeat expansion in Huntington’s; plus AAVs for kidney and T cells
Items per page:
1 - 10 of 990